[Retracted] Ternary Complexation Process for New Spectrophotometric Assay of Levodopa using Ni(II) and 2,3-Diaminopyridine

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Interferences</td><td class="align_center">Tolerable values</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Glucose, lactose, starch</td><td class="align_center">280</td></tr><tr><td class="align_left">Zn<sup>2+</sup>, Mg<sup>2+</sup>, Ca<sup>2+</sup>, Na<sup>+</sup>, and K <sup>+</sup></td><td class="align_center">850</td></tr><tr><td class="align_left">Citric acid, magnesium stearate</td><td class="align_center">160</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Tolerable limits of 10 <i>μ</i>g·mL<sup>−1</sup>LD using the proposed procedure.</div>

Advances in Materials Science and Engineering

tab6

Table 6

Table 6: [Retracted] Ternary Complexation Process for New Spectrophotometric Assay of Levodopa using Ni(II) and 2,3-Diaminopyridine 